34 participants
Intrathecal Dual Checkpoint Inhibitor (PD-1 and CTLA-4) in Combination With Pemetrexed for Leptomeningeal Metastasis
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-21
- Start Date:
- 2025-03-17
- Completion:
- 2026-12-01
Conditions
- Leptomeningeal Metastasis
- Pemetrexed
- PD-1 Inhibitor
- CTLA4
- Solid Tumors
Interventions
- DRUG
No Results Yet